Key Capital Coronavirus Treatment Advantage
10 mars 2020 09h30 HE
|
Key Capital Corporation
Key Capital’s KV-C19 Vaccine Candidate Offers Rapid, Effective And Cost-efficient Covid-19 Treatment Potential PHOENIX, AZ, March 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – KEY CAPITAL...
Key Capital Seeks Partners for Development of KV-C19 Coronavirus Therapeutic Vaccine Using Proven Immunotherapy Platform
05 mars 2020 14h49 HE
|
Key Capital Corporation
KV-C19 is believed to have the potential to successfully treat COVID-19 and ARDS (acute respiratory distress syndrome), the leading cause of COVID-19 deaths PHOENIX, AZ, March 05, 2020 (GLOBE...
Key Capital Acquires 20% of GoldVault
14 nov. 2019 11h00 HE
|
Key Capital Corporation
GoldVault Offers Gold Savings Incentives up to 50 Times Better Than Bank Interest PHOENIX, AZ, Nov. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – KEY CAPITAL CORPORATION (OTC Pink: KCPC)...